Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CSF immune complexes in multiple sclerosis.

P K Coyle

    Neurology
    |March 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Immune complexes in cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients suggest a role for viral reactivation or myelin breakdown in MS exacerbations. These findings point to potential intrathecal origins distinct from serum complexes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Should Age 65 be a cutoff for Primary Progressive Multiple Sclerosis therapy? Real World Data is Critical.

    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2023
    Same author

    Common Neurologic Features of Lyme Disease That May Present to a Rheumatologist.

    Pathogens (Basel, Switzerland)·2023
    Same author

    Therapy Optimization in Multiple Sclerosis: a cohort study of therapy adherence and risk of relapse.

    Multiple sclerosis and related disorders·2015
    Same author

    Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events.

    BMJ open·2014
    Same author

    Pregnancy and multiple sclerosis.

    Neurologic clinics·2012
    Same author

    Disease-modifying agents in multiple sclerosis.

    Annals of Indian Academy of Neurology·2010
    Same journal

    Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

    Neurology·2026
    Same journal

    Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

    Neurology·2026
    Same journal

    At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

    Neurology·2026
    Same journal

    Cerebral Artery Pulsatility, Premorbid Blood Pressure, and Small Vessel Disease on Brain Imaging: A Population-Based Study.

    Neurology·2026
    Same journal

    Genetic Risk for Alzheimer Disease, Midlife Hypertension, and Dementia: The ARIC Neurocognitive Study.

    Neurology·2026
    Same journal

    What is the Relevance of Neuron-Tumor Interactions in Malignant CNS Tumors?

    Neurology·2026
    See all related articles

    Area of Science:

    • Neuroimmunology
    • Virology
    • Neuropathology

    Background:

    • Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.
    • The exact triggers for MS exacerbations remain incompletely understood.
    • Immune complex formation in the central nervous system (CNS) may contribute to disease pathogenesis.

    Purpose of the Study:

    • To investigate the composition and origin of immune complexes in the cerebrospinal fluid (CSF) of individuals with MS exacerbations.
    • To compare CSF immune complexes with those found in serum.
    • To explore potential etiological factors in MS exacerbations.

    Main Methods:

    • Isolation and characterization of immune complexes from CSF samples of 12 individuals (6 MS exacerbations, 6 controls).

    Related Experiment Videos

  • Analysis of complexed antigens, including viral components (herpes simplex type I) and CNS-specific molecules (myelin basic protein, brain glycolipids).
  • Comparison of CSF immune complex profiles with serum immune complexes.

    • Main Results:

    • Immune complexes containing herpes simplex type I antigen-antibody were found in 3 MS patients.
    • Complexes with myelin basic protein were identified in 3 MS patients.
    • Antibodies against brain glycolipids were detected in 2 MS patients and 1 control.
    • CSF immune complexes differed from serum complexes, indicating an intrathecal origin.

    Conclusions:

    • Immune complex composition in MS CSF suggests involvement of viral reactivation and myelin damage.
    • Intrathecal origin of CSF immune complexes highlights local immune responses within the CNS.
    • Reactivation of latent brain viruses is a potential factor contributing to MS exacerbations.